Drug Pricing

Today President Trump promised (again) that he would bring down drug prices and put American patients first. The administration’s approach is to change how Medicare Part B (coverage available as an option for American residents when they are 65 years old or older, or if they qualify through a disability) pays for some of the most expensive prescription drugs, and attempts to imitate (irony alert) what President Trump blames other countries for doing: negotiating prices for their citizens, based largely upon the foreign prices themselves. A planned “international pricing index” (IPI), would cap certain Medicare Part B drug prices to an index from 16 otherRead More →